Citigroup »

Ovid Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $32k 10k 3.22
2023-09-30 $111 29 3.83
2022-12-31 $2.3k 1.2k 1.86
2022-09-30 $2.0k 1.2k 1.68
2021-12-31 $7.0k 2.1k 3.40
2021-03-31 $18k 4.4k 4.13
2020-12-31 $24k 11k 2.28
2020-09-30 $36k 6.3k 5.70
2020-06-30 $43k 5.8k 7.37
2020-03-31 $15k 5.1k 2.93
2019-12-31 $2.1M 502k 4.15
2019-09-30 $5.0k 1.5k 3.36
2019-06-30 $4.0k 2.0k 2.02
2019-03-31 $7.0k 3.5k 2.00
2018-12-31 $8.7k 3.5k 2.51
2018-09-30 $20k 3.6k 5.54
2018-03-31 $10k 1.5k 6.85
2017-12-31 $5.5k 513 10.71
2017-06-30 $301k 29k 10.50